3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
5
Thoracic Neoplasms
1
Solitary Pulmonary Nodule
1
Neoplasms by Site
1
Neoplasms
1
Multiple Pulmonary Nodules
1
Mesothelioma, Malignant
1
Lung Diseases
1
Esophageal Neoplasms
1
Interventions
Carboplatin
15
Pemetrexed
8
Paclitaxel
6
pembrolizumab
5
osimertinib
4
atezolizumab
4
Gemcitabine
4
Erlotinib Hydrochloride
4
entinostat
3
durvalumab
3
Cisplatin
3
selpercatinib
2
pralsetinib
2
camrelizumab
2
apatinib
2
Vinorelbine
2
Radiosurgery
2
Nivolumab
2
Injections
2
Gefitinib
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
toripalimab
1
taletrectinib
1
sotorasib
1
sintilimab
1
repotrectinib
1
pegylated granulocyte colony-stimulating factor
1
patritumab
1
necitumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thoracic Neoplasms
×
Indocyanine Green
×
Thoracic
×
Clear all
NCT02111824
2021-09-17
MIMIG
The Methodist Hospital Research Institute
Phase 1
Terminated
7 enrolled